Background Two models are mostly used to predict survival in cirrhosis: the Child-Pugh score (CP score) and the model for end-stage liver disease score (MELD score). Aims The aim of this study is to evaluate the CP score and the MELD score for short-and long-term prognosis in cirrhosis, as well as CP-creatinine score, MELD-Na score, and UKELD score. Methods One thousand and forty-seven patients from five referral centers were included: men/women: 620/427, median age: 58 years (IQR 48-66), median follow-up: 33 months (IQR 12-74), CP (A/B/C): 493/357/147, CP score: 7 (IQR 5-9), MELD score: 12 (IQR 9-16). The performance of each score was evaluated by the Cox hazard model in terms of their: discrimination ability (C-index and Somer's D) and calibration (3, 12 months).
Introduction
Liver cirrhosis has been subclassified into clinical stages reflecting differences in mortality rates [1] . Thus, a score that can accurately predict mortality is of major importance. Two models are mostly used in clinical practice: Child-Pugh grade/score (CP score) and model for endstage liver disease score (MELD score). However, both were developed for short-term prognosis following procedures for portal hypertension, namely portacaval shunt for CP score [2] and transjugular intrahepatic portosystemic shunt (TIPS) for MELD score [3] .
Several studies have compared the performance of both scoring systems in predicting survival with conflicting results. In a systematic review [4] comparing the prognostic accuracy of MELD score versus CP score, only 4 of 11 studies including 12,532 patients showed a superiority of MELD score compared to CP score in predicting 3-month survival. Moreover, the discriminative ability of MELD score to predict mortality following liver transplantation was poor [concordance (c) statistic below 0.7 in all six studies].
Apart from the short-term prognostic utility, both models have limitations [5] . CP score has not been validated statistically and uses clinically assessed ascites and encephalopathy which can be influenced by subjective interpretation. On the other hand, MELD score needs computation and lacks the simplicity of the CP score [6] .
These limitations have led to the development of variants of the original scoring systems, including MELD-Na score (including serum sodium, a significant predictor of early mortality, and indirect indicator of the presence of ascites) [7, 8] and CP-creatinine score (which includes renal function in order to increase its predictive accuracy) [9] .
We conducted this multicenter cohort study to evaluate MELD score, CP score, MELD-Na score, CP-creatinine score, and United Kingdom end-stage liver disease (UKELD score) score as prognostic models for long-term prognosis as well as for 3-, 6-, and 12-month survival in patients with stable cirrhosis taking into consideration the conflicting results in the literature.
Patients and Methods

Study Population
This is a multicenter retrospective cohort study including consecutive outpatients with cirrhosis between 1974 and 2012 in five referral centers: (a) Department of Gastroenterology, University Hospital, Patras, Greece (n = 496), (b) The Royal Free Sheila Sherlock Liver Centre, Royal Free Hospital and University College School of Medicine, London, UK (n = 341), (c) 4th Department of Internal Medicine, Hippokration General Hospital of Thessaloniki, Medical School of Aristotle University, Greece (n = 104), (d) 2nd Academic Department of Internal Medicine, University of Athens, Hippokration General Hospital, Athens, Greece (n = 102), and (e) Department of Gastroenterology, Polyclinic General Hospital, Athens, Greece (n = 92). The included patients were recruited from the hepatology clinics of the physicians that participated in the study. The study was compliant with the ethical standards of the Declaration of Helsinki. There were 1135 patients with cirrhosis. Patients with hepatocellular carcinoma (HCC) (n = 78) at baseline and those with no information on any of the prognostic scores under investigation (n = 10) were excluded from the analysis. None of the patients had concomitant human immunodeficiency virus (HIV) infection. The study cohort finally included 1047 patients.
Diagnosis of cirrhosis was based on clinical, laboratory, and previous radiological and histological findings. The management according to etiology of cirrhosis was based on international practice guidelines [10] [11] [12] [13] . None of the patients with HCV cirrhosis had sustained virological response before enrollment. In patients enrolled before 1990, diagnosis of HCV infection was documented later and these patients were included in the ''HCV etiology'' cohort or in ''other etiology'' cohort, if HCV seropositivity was not confirmed. Medical history, physical examination, and laboratory tests were available in all patients at their first admission. The definitions of diabetes mellitus, chronic kidney disease, hypertension, ischemic heart disease, and chronic respiratory diseases (including chronic obstructive pulmonary disease, asthma, obstructive sleep apnea syndrome, bronchiectasis, pulmonary hypertension) were based on the workup of the attending physician according to the current internationally accepted guidelines. Patients were followed up by experienced hepatologists until death, liver transplantation, study closure, or last contact with the health system. The management of moderate/severe ascites, spontaneous bacterial peritonitis, hepatorenal syndrome, hepatic encephalopathy, and acute variceal bleeding was according to the international practice guidelines as published at the time of enrollment. The final status (alive, transplanted, death) was recorded.
End-Points and Definitions
The primary end-point was the comparison of the prognostic accuracy of the different models regarding mortality at 3, 6, and 12 months and at the end of follow-up. We also performed a subgroup analysis for different etiologies of liver disease and for patients with MELD score C15. CP score, MELD score, MELD-Na score, and UKELD score were assessed as previously described [2, [14] [15] [16] [17] . CP-creatinine score was calculated as CP score ? 1, 2, or 3 (if creatinine\1.3, 1.3-1.5, and C1.5 mg/dl, respectively) [9] . Regarding PBC patients, the Mayo risk score [18] and the Royal Free score [19] were also calculated; CP score was assessed as suggested by Pugh et al. [2] . Only PBC patients with histological staging of 3 and 4 were included [20] .
Statistical Analysis
Categorical characteristics were summarized as counts and corresponding percentages, while medians and interquartile ranges (IQRs) were given for the continuous characteristics. Predictors of overall survival were evaluated using Cox proportional hazards models. Patients were censored at the last follow-up date or at the date of liver transplantation. The discrimination ability of each proposed prognostic score was assessed by both the C-index and the Somer's D [21] . To adjust for overfitting, our results were internally validated with bootstrapping [22, 23] . Comparisons of the C-index across different models were performed using nonparametric tests [24] . As a second aspect of models' validity, the calibration plots at 3 and 12 months were presented [25] .
For illustration, dynamic/incident receiver operating curve (ROC) suitable for survival data is presented at 3, 6, and 12 months of follow-up using the risk-set package in R, based on previously published work [26] .
To account for known confounders, all scores were evaluated separately in multivariable models adjusted for age, sex, ischemic heart disease, total bilirubin, creatinine, sodium, INR, albumin, encephalopathy, and ascites. The variables were adjusted depending on the components of the scores, excluding factors incorporated into the definition of the score; for instance, sodium, INR, bilirubin, and creatinine were not included in the model when MELD-Na score was evaluated.
Several sensitivity analyses were carried out: (a) to account for potential differences across centers, analysis was repeated after including the different centers in both the univariable and multivariable models; (b) subgroup analyses among those with and without decompensation as well as among those with and without anti-HBV treatment were performed. All analyses were performed with Stata11.2.
Institutional Review Board Statement
The study was reviewed and approved by the Ethics committee of University Hospital of Patras.
Results
A total of 1047 patients were included in the analysis. Patients' characteristics are presented in Table 1 (Table 2 ), but this difference was not significant when compared to CP score. Subgroup analysis showed that all scores performed better in patients with compensated compared to those with decompensated cirrhosis, although the CP-creatinine score performed overall better than the other examined scores, as in the main analysis (Suppl. Table 1 ). The C-indexes of CP score and CP-creatinine score were significantly higher compared to MELD score, MELDNa score, or UKELD score (Table 3 ). Sensitivity analysis after Dig Dis Sci (2017) 62:1363-1372 1365 inclusion of the centers together with each predictive score in a model yielded similar results (data not shown).
The dynamic/incident receiver operating characteristic (ROC) curves of CP score, CP-creatinine score, MELD score, MELD-Na score, and UKELD score for 3-, 6-, and 12-month survival are shown in Fig. 1a -c. CP-creatinine score and CP score had the best discriminative ability for all time points. Nevertheless, given that the C-index was relatively low in all cases (a C-index equal to 0.5 is were estimated (a) using the whole sample (i.e., naïve) and (b) as the average of 100 bootstrap samples expected by chance and the Somer's D was well below 1), the discrimination ability of all prognostic scores was moderate to low.
Patients with Alcoholic, Viral Cirrhosis, and MELD Score C15
In the subgroup analysis of patients with alcoholic and viral cirrhosis, the results were the same as in the total population, with CP-creatinine score and CP score performing better than the other prognostic scores [bootstrap C-index (95% CI) 0.630 (0.579-0.681) and 0.626 (0.569-0.684), respectively, for alcoholic cirrhosis, and 0.691 (0.652-0.730) and 0.688 (0.643-0.732), respectively, for viral cirrhosis] (Suppl. Table 2 ). In patients with MELD score C15, CP-creatinine score performed overall better than the other scores with a bootstrap C-index of 0.632 (95% CI 0.576-0.688) (Suppl. Table 2 ). The comparison of the C-indexes between the scores for the subgroup analyses is shown in Suppl. Table 3 . A separate analysis was performed for patients with HBV cirrhosis to explore if there were any differences in the prognostic accuracy of the scores between patients included in the study before and after the year 2000 in order to assess their performance before and after the era of nucleot(s)ide analogues. No differences were observed (data not shown). However, when data were divided according to anti-HBV therapy, all scores performed better in patient treated for HBV compared to untreated patients, but the order of the relative performance was similar to that of the main analysis (Suppl. Table 4 ).
Predictive Factors for Overall Survival
Univariable Analysis
Univariate analysis using Cox proportional hazards model showed that advanced age, male sex, ischemic heart disease at baseline, INR, total bilirubin, albumin, creatinine, sodium, encephalopathy, and ascites at baseline were significantly associated with survival (Suppl. Table 5 ). Moreover, all the prognostic models (CP score, CP-creatinine score, MELD score, MELD-Na score, and UKELD score) were significantly associated with overall mortality (Table 2) .
Multivariable Analysis
Total Population Multivariate Cox regression analysis for overall survival including all significant baseline In all cases, differences between naïve and bootstrap estimates were small, indicating that optimism was negligible in all cases. There were no differences between the C-indexes derived by the multivariable models for all prognostic scores of interest (Suppl. Table 7) .
Patients with Viral, Alcoholic Cirrhosis, and MELD Score C15 When the same analysis was performed in patients with viral cirrhosis, the results were similar to the above mentioned with age being significant for CP-creatinine score, and albumin, age, and ascites for MELD-Na score (or UKELD score) score. In the subgroup analysis of patients with alcoholic cirrhosis and in those with MELD score C15, age was the only factor found statistically significant for all prognostic scores (data not shown).
Primary Biliary Cirrhosis (PBC)
Comparison of the Predictive Models (CP, CP-Creatinine Score, MELD Score, MELD-Na Score, UKELD Score, PBC RFH, and Mayo Risk Score) for 3-, 6-, 12-Month and Overall Survival (Table 4) . The comparison of the C-indexes between scores showed that UKELD score, PBC RFH, and Mayo risk scores had significantly higher diagnostic accuracy compared to CP score. The dynamic/incident ROC curves of CP, CP-creatinine score, MELD score, MELD-Na score, UKELD score, Mayo risk, and PBC RFH scores for 3-, 6-, and 12-month survival in patients with PBC are shown in Fig. 2a-c . UKELD score had the highest discriminative ability for 3-and 6-month survival, but in 12-month PBC RFH and Mayo risk scores performed better than all other scores (Table 5 ).
Predictive Factors for Overall Survival
All prognostic scores were associated with overall mortality in the univariable analysis. Results from multivariable Cox regression analysis including all significant baseline characteristics together with each prognostic score are shown in Suppl. Table 8 . Age was the only factor that was statistically significant for all prognostic scores, apart from Mayo risk and PBC RFH scores which already incorporate age. The addition of age in the Cox multivariable model increased the C-index and the Somer's D of each predictive score (Suppl. Table 8 ). Regarding PBC RFH and Mayo risk scores, creatinine was independently associated with overall survival. Male sex was also independently associated with worse survival when tested together with PBC RFH score. The comparison between the C-indexes of each multivariable model showed no statistical significance, apart from MELDNa score/Age model that was found significantly better than CP-creatinine score/age model [bootstrap C-index (95% CI) 0.96 (0.896-1.02) and 0.897 (0.794-1.001), respectively] (Suppl. Table 8 ). Hazard ratio estimates are based on the whole dataset. Discrimination measures, i.e., C-index and Somer's D, were estimated (a) using the whole sample (i.e., naïve) and (b) as the average of 100 bootstrap samples
Calibration
Calibration between observed and predicted survival probabilities was good in the majority of the models, both at 3 and 12 months. The CP-creatinine score demonstrated the best calibration (Suppl. Figure 1a -l) when tested in the total population.
Discussion
The present study clearly demonstrates the superiority of CP and CP-creatinine scores to predict both short-and long-term survival in a large population of outpatients with cirrhosis compared to MELD score, MELD-Na score, or UKELD score. The main advantage of this study is that it takes into account other chronic diseases such as ischemic heart disease or diabetes mellitus that might independently affect mortality. The incorporation of age increased the predictive accuracy of the models. Advanced age is associated with a longer duration of chronic liver disease, reduced cellular regeneration, and immune surveillance, and there are data supporting its prognostic significance [1, 27] .
The advantages of MELD score lie in the statistically weighted ''markers'' and the inclusion of creatinine [5] , while CP score is a simple score without need for complex computations [5] . However, while CP score weighs all variables equally, MELD score weighs them in a nonlinear fashion. The performance of MELD score and CP score has been compared with conflicting results [28] [29] [30] . The majority of the studies that included patients undergoing TIPS placement showed an equal performance for 3-and 12-month mortality apart from a study by Salerno et al. [28] in which MELD score performed significantly better than CP score for 3-month mortality [31] . In the studies that included patients without TIPS placement, the predictive accuracies of the MELD score and CP score were equal, with higher performance at 3 and 6 months and progressively lower at longer time periods [27, 31] . In the present study, CP and CP-creatinine score had a significantly higher predictive accuracy than MELD score or MELD-Na score for overall mortality. The discrepancies between our study and the study by Said et al. [27] can be related to the lower proportion of HCV and higher proportion of PBC patients, the inclusion of outpatients, the longer follow-up period, and the lower incidence of Fig. 2 Dynamic/incident ROC curves of Child-Pugh, Child-Pugh creatinine score, MELD score, MELD-Na score, and UKELD score for a 3-month, b 6-month, and c 12-month survival in patients with primary biliary cirrhosis patients undergoing liver transplantation in our study. However, our findings are consistent with those reported by D'Amico et al. [1] . Since no renal parameter was taken into account in the original CP score, a modified CP score including serum creatinine as a dichotomous variable was developed [32] . In the study by Angermayer et al. [32] , the c-statistics for 3-month survival for CP score, MELD score, and CP-creatinine score in patients undergoing TIPS were similar. In contrary, Giannini et al. [33] found that in the prediction of 3-month mortality, the c-statistic of MELD score (0.947) was marginally better compared to CP-creatinine score, but significantly higher compared to CP score (0.757). Papatheodoridis et al. [9] evaluated the predictive value of CP score, MELD score, and creatinine-modified CP score in 102 patients with decompensated cirrhosis. The AUROCs for 3-, 6-, 12-, and 24-month mortality did not differ significantly among the four scores. In a recent publication, Kaplan et al. [34] adjusted CP score outpoints to improve predictive capacity and evaluated a modified CP-creatinine score. They concluded that the modified CP score and creatinine-modified CP score models showed superiority over the original CP score and MELD score in predicting 1-, 2-, 3-, 4-, and 5-year transplant-free survival [34] . In our study, which included both compensated and decompensated cirrhotics, the addition of creatinine in CP score did not significantly improve its accuracy. When we divided our patients into two groups (with and without decompensation) and performed subgroup analysis, all scores performed better in patients without decompensation compared to those with compensated cirrhosis, although the CP-creatinine score performed better. These discrepancies might reflect the differences in the study populations, the cutoffs used for creatinine, the length of followup periods, and the variations in creatinine measurements among different laboratories. It seems that the superiority of MELD score in patients awaiting for liver transplantation [15] relies on the fact that this cohort has renal impairment [35] . Apparently, creatinine has little impact on the non-transplant setting and stable cirrhosis.
It has been suggested that the inclusion of other factors to the original MELD score may offer additional prognostic value [5, 15, 32, 36, 37] . Although mortality rates in patients with cirrhosis who develop complications are higher [38] [39] [40] , MELD score fails to predict this impact on survival [1] . It has been suggested [8] that the addition of serum sodium to MELD score can improve its accuracy [41, 42] . In the present study, no differences were observed between the prognostic performances of MELD score and MELD-Na score or UKELD score similarly to the study by Boursier et al. [29] . Londono et al. [43] found that MELD score and serum sodium concentration were the only independent predictors of 3-and 12-month survival, but the addition of serum sodium did not significantly improve its accuracy. We did not observe independent associations between serum sodium and overall mortality.
In the present study, the performance of models predicting long-term survival was poor compared to other studies [29, 36] . However, the prognostic performance of both MELD score and CP score is lessened over time [28] .
Cirrhosis is a dynamic entity [44] , and repeated assessment of scoring systems is needed [27] . In patients with MELD score C15, a superiority of CP-creatinine score was observed. This MELD score cutoff was used considering that a major change in survival probability occurs at this threshold [45] . Most importantly, the incorporation of creatinine as a trichotomous variable in CP score seems to have a higher performance for long-term survival compared to its inclusion in MELD score as a continuous variable in high risk patients.
The data on the impact of etiology on liver disease are scarce. The original MELD score [3] incorporated etiology, but it was removed later when Kamath et al. [37] showed that etiology had a little impact on its accuracy [15] . In our study, in patients with viral and alcoholic etiology, CP-creatinine score and CP score had the highest predictive accuracy as in the total population. The performance of MELD score, MELD-Na score, and UKELD score was better in viral, compared to alcoholic cirrhosis. This suggests that in patients with alcoholic cirrhosis other factors such as active alcohol drinking contribute to long-term mortality.
Another important observation is that, in HBV cirrhosis, all scores performed equally irrespective of the year of enrollment, i.e., before or after the year 2000, when anti-HBV treatment with lamivudine was initiated. This implies that the models have equal diagnostic accuracy independent to the initiation of antiviral treatment. Moreover, when we divided the patients into two groups according to the receipt or not of anti-HBV therapy, all scores performed better in patient treated for HBV compared to untreated patients; however, the order of the relative performance was similar to that of the main analysis.
In patients with PBC, UKELD score, Mayo risk, and RFH-PBC scores had excellent and equal accuracy to predict long-term mortality and they performed significantly better compared to CP, MELD score, and their modified versions. In our knowledge, this is the first study to confirm the excellent performance of UKELD score in PBC patients during a long follow-up period. In ROC curve analysis, the UKELD score performance was better for the prediction of 3-and 6-month survival, while the Mayo risk and RFH-PBC scored better for the 12-month mortality risk. This is not surprising, considering that UKELD score was developed specifically for patient awaiting liver transplantation in a short-term follow-up, whereas the other two scores were built to predict 24-month mortality.
The present study is subject to certain limitations. Firstly, it has a retrospective/prospective design. However, all variables were collected prospectively by experienced physicians in well-organized medical databases. There were few missing values, and our results are consistent with those observed by others [29] . Secondly, we included a large number of patients with PBC who have a survival benefit compared to alcoholic or viral-related cirrhotics [46] . However, PBC patients have been included in many other similar studies [9, 37, 47] . Thirdly, there was a small number of transplanted patients in our cohort compared to other studies [27] . However, due to the small number of liver transplant centers in Greece and the high demand for organs, a large number of patients will not be eventually transplanted. Thus, our results have also important implications in liver centers with no transplantation facilities. The confounding probability related to the various differences among the hospitals (standard of care, different distribution of disease etiology, differences in the laboratory tests used, time period of recruitment) was addressed in a sensitivity analysis. All conclusions regarding the effect of the prognostic scores in terms of hazard ratios, as well as their predictive ability in terms of C-indexes, remained intact indicating no confounding probability. Another limitation of this study is that we included only baseline characteristics as predictive factors of survival in order to reach conclusions useful in the everyday clinical practice and to avoid bias related to missing values.
In conclusion, CP score and CP-creatinine score are superior to MELD score, MELD-Na score, and UKELD score for the prediction of short-term and long-term mortality. Although CP score is likely to need statistical validation, it should not be abandoned in clinical practice.
